- Home
- DSGN vs MCFT Comparison
DSGN vs MCFT Comparison
Compare DSGN & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- MCFT
- Stock Information
- Founded
- DSGN 2017
- MCFT 1968
- Country
- DSGN United States
- MCFT United States
- Employees
- DSGN N/A
- MCFT N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- MCFT Marine Transportation
- Sector
- DSGN Health Care
- MCFT Industrials
- Exchange
- DSGN Nasdaq
- MCFT Nasdaq
- Market Cap
- DSGN 348.2M
- MCFT 286.5M
- IPO Year
- DSGN 2021
- MCFT 2015
- Fundamental
- Price
- DSGN $4.01
- MCFT $17.24
- Analyst Decision
- DSGN Buy
- MCFT Buy
- Analyst Count
- DSGN 2
- MCFT 4
- Target Price
- DSGN $8.00
- MCFT $20.50
- AVG Volume (30 Days)
- DSGN 156.4K
- MCFT 81.1K
- Earning Date
- DSGN 03-10-2025
- MCFT 05-07-2025
- Dividend Yield
- DSGN N/A
- MCFT N/A
- EPS Growth
- DSGN N/A
- MCFT N/A
- EPS
- DSGN N/A
- MCFT N/A
- Revenue
- DSGN N/A
- MCFT $311,260,000.00
- Revenue This Year
- DSGN N/A
- MCFT N/A
- Revenue Next Year
- DSGN N/A
- MCFT $20.29
- P/E Ratio
- DSGN N/A
- MCFT N/A
- Revenue Growth
- DSGN N/A
- MCFT N/A
- 52 Week Low
- DSGN $3.15
- MCFT $16.12
- 52 Week High
- DSGN $7.77
- MCFT $24.05
- Technical
- Relative Strength Index (RSI)
- DSGN 40.65
- MCFT 44.21
- Support Level
- DSGN $4.06
- MCFT $17.03
- Resistance Level
- DSGN $5.09
- MCFT $17.85
- Average True Range (ATR)
- DSGN 0.38
- MCFT 0.57
- MACD
- DSGN -0.08
- MCFT 0.04
- Stochastic Oscillator
- DSGN 9.93
- MCFT 16.09
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About MCFT MasterCraft Boat Holdings Inc.
MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.